DOCS
Doximity Inc
26.40$
+1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +19.1% | -12.7% | +7.3% | +8.0% | +23.2% | -18.0% | +5.5% | +15.5% | +9.8% | -21.4% | +7.7% | – | |
| – | -4.5% | +3.1% | +7.8% | +0.9% | +3.7% | +2.0% | +9.2% | +4.0% | +13.9% | +3.8% | +22.1% | – | |
| – | +22.1% | -14.3% | +7.2% | +8.9% | +25.4% | -19.8% | +5.1% | +16.9% | +9.4% | -24.3% | +5.5% | – | |
| – | -0.1% | +1.0% | +12.0% | +3.0% | -3.5% | +10.6% | +8.0% | +12.7% | +14.5% | +13.0% | -1.6% | – | |
| – | +7.5% | +3.4% | -7.2% | +9.2% | +34.5% | -6.3% | -2.3% | +53.1% | -7.3% | -8.7% | -2.3% | – | |
| – | -3.8% | -1.4% | +5.4% | +4.4% | +6.4% | +0.9% | +0.6% | +17.0% | +6.8% | +7.1% | -1.8% | – | |
| – | +73.3% | -28.5% | +10.0% | +15.4% | +50.4% | -39.1% | +12.0% | +16.8% | +12.9% | -65.5% | +35.5% | – | |
| – | +58.8% | -23.9% | +10.9% | +16.9% | +44.5% | -35.0% | +9.9% | +13.7% | +10.8% | -60.2% | +25.7% | – | |
| – | +65.8% | -51.3% | +60.8% | +52.8% | -18.7% | -127.8% | – | +0.5% | +76.8% | -32.4% | +23.4% | – | |
| – | +56.7% | -15.3% | +1.9% | +6.7% | +70.3% | -16.9% | -14.6% | +16.4% | -0.8% | -68.9% | +27.2% | – | |
| – | +47.8% | -22.9% | +10.4% | +4.2% | +59.3% | -33.8% | +9.3% | +16.7% | +8.6% | -57.2% | +23.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.